Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Cagrilintide: Long-acting amylin analog explained What cagrilintide is: Synthetic analog of human amylin hormone Also called "pramlintide long-acting" (related compound) Developed by Novo Nordisk Currently investigational (Phase 3 trials) Not yet FDA approved (as of 2024) Weekly subcutaneous injection Natural amylin background: Peptide hormone co-secreted with insulin Made by pancreatic beta cells Released after meals in response to nutrients Important satiety signal Regulates postprandial glucose Deficient in diabetes Why synthetic cagrilintide was developed: Natural amylin very short half-life (minutes) Impractical for treatment Cagrilintide engineered for long duration Weekly dosing vs multiple daily injections Better pharmacokinetics Enhanced stability Learn about peptides , how peptides work , and what are peptides used for at SeekPeptides
Small number of research groups : A limited number of research groups have conducted most studies, which may affect the generalizability of the results
Blood Sugar Control : After you eat, your body produces insulin to help move sugar from your blood into your cells for energy
G., Tobn-Velasco, J
(PubMed) Witting PK, Pettersson K, Letters J, Stocker R
US$ 23.86
US$ 23.10
US$ 24.74
US$ 23.74
US$ 24.50
US$ 27.96
US$ 22.79
US$ 25.34
US$ 20.65
